- Offices located in Norristown, Philadelphia, and King of Prussia, PA
Are you or a loved one struggling with Opioid Use Disorder (OUD)?
If you’ve been searching for a treatment that offers a real chance at a new life, look no further. Dr. Watson is at the forefront of addiction treatment, offering a new pathway to freedom: Sublocade®.
Sublocade® is an extended-release Buprenorphine injection designed to treat opioid addiction as part of a complete Medication Assisted Treatment (MAT) plan. Unlike oral medications like Suboxone® that require daily dosing, Sublocade® is administered once a month, providing continuous relief and making it easier to stay committed to your treatment.
Sublocade® slowly releases buprenorphine into the body, helping to suppress withdrawal symptoms, reduce cravings, and stabilize your life. Unlike daily oral medications, its once-monthly administration helps you maintain constant levels of the drug in your system, reducing the highs and lows associated with daily dosing.
Administered as a once-monthly injection, Sublocade® simplifies OUD treatment and eliminates the common pitfalls associated with daily oral medications. Since 2018, Dr. Watson has successfully helped hundreds transition to this effective, long-acting MAT method.
Sublocade® Injections are a cutting-edge treatment option for opioid addiction.
These monthly injectable medications contain buprenorphine, a proven medication that reduces cravings and withdrawal symptoms. Unlike daily oral medications, Sublocade® provides sustained release of buprenorphine, ensuring consistent levels in the body.
With Sublocade® Injections, individuals can experience the benefits of effective treatment while minimizing the risk of missed doses or misuse.
Why Choose Dr. Watson – The PA Suboxone® Doctor
Dr. Watson is one of the nation’s trailblazers in providing Sublocade® treatment – the once-monthly extended-release Buprenorphine injection designed to transform lives affected by Opioid Use Disorder (OUD).
With over six years of experience administering this game-changing medication, Dr. Watson has successfully guided hundreds of patients from daily oral medication to this long-acting MAT (Medication Assisted Treatment) alternative.
Dr. Watson’s specialized Sublocade® treatment plan presents a range of unparalleled advantages:
With a once-monthly administration, Sublocade® ensures you don’t miss a dose. Transitioning from 365 days of dosing to just 12, this MAT option is the most convenient.
No more discomfort from the unpleasant taste of oral buprenorphine.
Sublocade® reduces gastrointestinal problems as it bypasses direct interaction with the gut.
With Sublocade®, there’s no risk of pediatric exposure, ensuring the safety of your medication.
Sublocade® is administered directly to the patient, eliminating any possibility of your medication being stolen or misplaced.
Administered in-office, Sublocade® saves you from frequent pharmacy visits.
Moving from oral buprenorphine to Sublocade® is a smooth process with Dr. Watson’s expert guidance. This treatment method offers increased freedom and flexibility, no longer requiring you to pack medication.
Notably, many of Dr. Watson’s patients have found that Sublocade® lasts longer than 4-6 weeks. Remarkably, some patients who chose to stop MAT reported minimal to no withdrawal symptoms after their final injection. This revelation points to the long-term effectiveness of Sublocade®.
Dr. Watson’s profound knowledge and experience stem from personally administering thousands of successful injections, leading to improved quality of life and superior outcomes for his patients. Experience the freedom from addiction with Dr. Watson’s groundbreaking Sublocade® treatment today.
Sublocade® Injections offer a range of benefits for individuals seeking relief from cravings and support in their journey towards sobriety.
Studies have demonstrated that these injections, which are based on buprenorphine, are highly effective in reducing cravings and lowering the risk of relapse. Moreover, Sublocade® plays a crucial role in effectively managing withdrawal symptoms by providing a consistent dose of buprenorphine. This helps minimize discomfort and instability during the recovery process, allowing individuals to focus on their journey toward healing.
In addition to its efficacy, Sublocade® offers convenience and improved treatment adherence. With monthly injections, individuals no longer need to worry about adhering to a daily medication schedule. This streamlined dosing regimen not only simplifies treatment but also enhances adherence, which has been linked to better treatment outcomes and reduced opioid use over the long term.
With Sublocade®, patients only need to worry about 12 doses a year, instead of 365. This remarkable convenience improves treatment compliance, ensuring a consistent dose of Buprenorphine is administered and eradicating the risk of missing a daily dose.
Direct Physician Care with Dr. Watson gives you access to a precise and focused route to recovery. This streamlined approach eliminates distractions, providing the best opportunity for a successful and enduring recovery.
The effects of a Sublocade® Injection typically last for about a month. Monthly injections ensure sustained relief from cravings and withdrawal symptoms, supporting your recovery journey.
Like any medication, Sublocade® Injections may have side effects. Common side effects include injection site reactions, constipation, headache, and nausea. Our medical professionals closely monitor and manage any potential side effects to ensure your comfort and well-being.
It is essential to consult with our medical professionals regarding the safety of Sublocade® during pregnancy or breastfeeding, as buprenorphine can have implications for both the mother and the baby.
Counseling and support services are highly recommended as part of a comprehensive treatment approach. They address the psychological and behavioral aspects of addiction, enhance coping skills, and promote long-term recovery. However, it is not generally required.
Sublocade® has shown significant effectiveness in reducing the risk of relapse by managing cravings and withdrawal symptoms. However, individual results may vary, and ongoing support and engagement in treatment are crucial for sustained recovery.
Disclaimer: Suboxone®® and Sublocade®® are registered trademarks of Indivior UK Limited. PASD is not affiliated with Indivior UK Limited or its affiliates (“Indivior”), and any reference to it or its intellectual property is for informational purposes only and is not endorsed or sponsored by Indivior.
